These results provide novel scientific evidence that the administration of Urd and AEtLP improves constipation-related symptoms and parameters in C3-deficiency-induced constipation through the regulation of mucin secretion, ENS function, and GI hormones. The gene discussed is MUC5AC; the disease is constipation disorder.